Canonical ingredient
Doxorubicin hydrochloride
DOXORUBICIN HYDROCHLORIDE
25 linked products
Official identifiers
CAS 25316-40-9ChEBI CHEBI:31522InChI InChI=1S/C27H29NO11.ClH/c1-10-22(31)13(28)6-17(38-10)39-15-8-27(36,16(30)9-29)7-12-19(15)26(35)21-20(24(12)33)23(32)11-4-3-5-14(37-2)18(11)25(21)34;/h3-5,10,13,15,17,22,29,31,33,35-36H,6-9,28H2,1-2H3;1H/t10-,13-,15-,17-,22+,27-;/m0./s1InChIKey MWWSFMDVAYGXBV-RUELKSSGSA-NSMILES COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1.Cl
Names and synonyms
- Doxorubicin hydrochloride (en)
- Chlorhydrate de doxorubicine (fr)
Safety and technical documents
General references and manufacturer-specific SDS documents are kept separate.
No verified SDS or technical sheet is linked yet. This absence is explicit and does not mean that no document exists.
End-to-end traceability
Only links supported by an identified source are published. Missing evidence remains explicitly unknown.
Evidence still missing
- Country or region of origin
- Raw-material producer
- Ingredient manufacturer
- Distributor
- Transformation steps
Documented origins
No origin has been proven yet by an explicit source.
Documented organizations
No organization has been proven yet by an explicit source.
Documented transformations
No transformation step has been proven yet by an explicit source.
Method: a company’s registration country is never used as evidence of a material’s origin.
Products containing this ingredient
ADRIAMYCIN PFS
2 · MG · ML
ADRIAMYCIN RDF
10 · MG · VIAL
ADRIAMYCIN RDF
50 · MG · VIAL
ADRIAMYCIN RDF
150 · MG · VIAL
ADRIAMYCIN RDF INJ 10MG/VIAL
10 · MG · VIAL
ADRIAMYCIN RDF INJ 150MG/VIAL
150 · MG · VIAL
ADRIAMYCIN RDF INJ 50MG/VIAL
50 · MG · VIAL
CAELYX
2 · MG · ML
DOXORUBICIN
2 · MG · ML
DOXORUBICIN HCL FOR INJ. U.S.P. 10MG/VIAL
10 · MG · VIAL
DOXORUBICIN HCL FOR INJ. U.S.P. 150MG/VIAL
150 · MG · VIAL
DOXORUBICIN HCL FOR INJ. U.S.P. 50MG/VIAL
50 · MG · VIAL
DOXORUBICIN HYDROCHLORIDE FOR INJECTION USP
10 · MG · VIAL
DOXORUBICIN HYDROCHLORIDE FOR INJECTION USP
50 · MG · VIAL
DOXORUBICIN HYDROCHLORIDE FOR INJECTION USP
150 · MG · VIAL
DOXORUBICIN HYDROCHLORIDE FOR INJECTION USP
50 · MG · VIAL
DOXORUBICIN HYDROCHLORIDE INJECTION
2 · MG · ML
DOXORUBICIN HYDROCHLORIDE INJECTION
2 · MG · ML
DOXORUBICIN HYDROCHLORIDE INJECTION
2 · MG · ML
DOXORUBICIN HYDROCHLORIDE INJECTION
2 · MG · ML
DOXORUBICIN HYDROCHLORIDE INJECTION, USP
2 · MG · ML
DOXORUBICIN INJECTION, BP
2 · MG · ML
MYOCET
2 · MG · ML
PEGYLATED LIPOSOMAL DOXORUBICIN HYDROCHLORIDE FOR INJECTION
2 · MG · ML
TARO-DOXORUBICIN LIPOSOMAL
2 · MG · ML